All posts in Uncategorized

Channel Medsystems Receives Health Canada Approval to Begin Clinical Evaluation of its Innovative Procedure for Heavy Menstrual Bleeding; Hires Mary Edwards as Senior Vice President, Clinical and Regulatory Affairs.

San Francisco, California. November 11, 2013. Channel Medsystems has received investigational testing authorization from Health Canada to begin enrolling patients in the Cryoablation Feasibility Trial (CRYSTAL), a multi-site clinical trial designed to evaluate its innovative cryothermic treatment for heavy menstrual bleeding due to benign causes. The CRYSTAL study is designed to evaluate the efficacy and tolerability of Channel Medsystems’ in-office cryothermic procedure. The Company expects to enroll its first patient in November.

More

Channel Medsystems® Names Ric Cote as President and CEO; Secures $9.7 Million Investment

San Francisco, Calif. — (May 2, 2013)—Channel Medsystems, Inc., named Ric Cote president and chief executive officer, and issued $9.7M of Series B Preferred Stock.

“Ric is an excellent fit due to our focus on creating the first truly office-based Global Endometrial Ablations technology,” said prior CEO and co-founder Dr. Dan Burnett. “We are hoping he can replicate his success at Conceptus where he successfully built revenues of their office-based procedure to over $140 million per year.”

More